Results 71 to 80 of about 4,228 (148)

A Machine-Learning Approach Identifies Rejuvenating Interventions in the Human Brain. [PDF]

Adv Sci (Weinh)
Santamaria G, Iglesias C, Jung S, Arcos Hodar J, Nogueiras R, Del Sol A.   +5 more
europepmc   +1 more source

Therapeutic advances in acute myeloid leukemia: from LSD1 blockade to PROTAC-based strategies. [PDF]

Ann Med Surg (Lond)
Khan SA, Qamar MA, Feroze MT.
europepmc   +1 more source

Rarely listed essential medicines in 158 national lists. [PDF]

J Pharm Policy Pract
Ul Haq MZ, Heredia C, Rizvi A, Workentin A, Persaud N.   +4 more
europepmc   +1 more source

The enhanced prescription: Adding value to consultations in psychiatry and other branches of medicine. [PDF]

Indian J Psychiatry
Andrade C, Menon V.
europepmc   +1 more source

Characterization of trazodone metabolic pathways and species-specific profiles. [PDF]

Front Pharmacol
Petrucci V, Dragone P, Laurenti MC, Oggianu L, Zabela V, Cattaneo A.   +5 more
europepmc   +1 more source

Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012-2024). [PDF]

Molecules
Alsaad I, Abdel Rahman DMA, Al-Tamimi O, Alhaj SA, Sabbah DA, Hajjo R, Bardaweel SK.   +6 more
europepmc   +1 more source

An Exploration of the Interplay Between Caffeine and Antidepressants Through the Lens of Pharmacokinetics and Pharmacodynamics. [PDF]

Eur J Drug Metab Pharmacokinet
Truong J, Abu-Suriya N, Tory D, Bahho R, Ismaiel A, Nguyen T, Mansour A, Nand V, Saponja J, Dua K, De Rubis G, Parisi D.   +11 more
europepmc   +1 more source

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids. [PDF]

J Med Chem
Chou PY, Lai MJ, Tsai KK, Cheng LH, Wu YW, Chen MC, Pan SL, Ho HO, Nepali K, Liou JP.   +9 more
europepmc   +1 more source

Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of <i>Schistosoma mansoni</i>. [PDF]

ACS Infect Dis
Fabbrizi E, Hailu GS, Ganesan A, Fioravanti R, Zwergel C, Lambona C, Valente S, Fianco G, Iuzzolino A, Trisciuoglio D, Caroli J, Mattevi A, Häberli C, Keiser J, Rotili D, Mai A.   +15 more
europepmc   +1 more source

Selegiline, a monoamine oxidase-B inhibitor as a modulator of metabolic reprogramming for cancer therapy: a review. [PDF]

Front Pharmacol
Jayachandran J, Nambidi S, Kondaveeti SB, Pathak S, Radhakrishnan A, Banerjee A, Dutta Roy AK.   +6 more
europepmc   +1 more source